BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $65,715,000 | +8732.7% | 434,703 | +8423.6% | 3.09% | +9867.7% |
| Q2 2022 | $744,000 | -82.6% | 5,100 | -85.9% | 0.03% | -80.0% |
| Q1 2022 | $4,279,000 | -33.7% | 36,100 | -22.9% | 0.16% | -32.3% |
| Q4 2021 | $6,450,000 | -3.9% | 46,800 | -3.1% | 0.23% | -19.6% |
| Q3 2021 | $6,709,000 | +48.3% | 48,300 | -8.5% | 0.28% | +63.8% |
| Q4 2020 | $4,525,000 | +29.2% | 52,800 | +10.2% | 0.17% | -12.1% |
| Q2 2020 | $3,502,000 | +183.6% | 47,900 | +32.0% | 0.20% | +104.1% |
| Q1 2020 | $1,235,000 | – | 36,281 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |